What analgesic regimen is appropriate for managing epigastric pain?

Pain Medication for Epigastric Pain

For chronic epigastric pain related to disorders of gut-brain interaction (functional dyspepsia, IBS), tricyclic antidepressants (TCAs) are the first-line analgesic choice, starting with amitriptyline or nortriptyline 10 mg at bedtime and titrating by 10 mg weekly to 30-50 mg based on response. 1

Algorithmic Approach to Analgesic Selection

Step 1: Identify the Underlying Cause

The appropriate analgesic depends critically on whether the epigastric pain is:

• Functional/chronic (functional dyspepsia, IBS) - where neuromodulators are indicated
• Structural (GERD, PUD, gastritis) - where treating the underlying condition takes priority over analgesics 2
• Acute/emergent (MI, pancreatitis, aortic dissection) - requires immediate evaluation, not chronic pain management

Step 2: For Chronic Functional Epigastric Pain

Primary Choice: Tricyclic Antidepressants (TCAs)

TCAs ranked first for efficacy in treating chronic gastrointestinal pain in network meta-analyses, even in patients refractory to proton pump inhibitors 1. The evidence is particularly strong:

• Starting regimen: Amitriptyline or nortriptyline 10 mg at bedtime
• Titration: Increase by 10 mg weekly or biweekly according to response and tolerability
• Target dose: 30-50 mg at night (maximum)
• Side effects to counsel on: Sedation, dry mouth, dry eyes, constipation 1

Important nuance: Secondary amines (nortriptyline, desipramine) have fewer anticholinergic side effects than tertiary amines (amitriptyline, imipramine), making them preferable in elderly patients or those sensitive to anticholinergic effects 1.

Second-Line: SNRIs (Duloxetine)

If TCAs are not tolerated or contraindicated:

• Starting dose: Duloxetine 30 mg once daily
• Titration: Up to 60 mg once daily based on response
• Evidence: High-quality evidence in other chronic pain conditions (fibromyalgia, low back pain), though less studied specifically for functional dyspepsia 1
• Side effects: Sedation, dry mouth, constipation or diarrhea, anxiety, reduced appetite, nausea, headache, fatigue 1

Third-Line: Mirtazapine

• Starting dose: 15 mg once daily
• Maximum: 45 mg once daily
• Note: More effective for early satiety than epigastric pain specifically, but recent trials show benefit for pain-free days in IBS 1
• Side effects: Sleep disorders, increased appetite and weight gain 1

Step 3: What NOT to Use

SSRIs are NOT effective - Network meta-analyses showed SSRIs were no more efficacious than placebo for chronic gastrointestinal pain 1. Avoid prescribing these for pain management in this context.

Common Pitfalls to Avoid

1. Starting doses too high: Always begin at 10 mg for TCAs to assess tolerability
2. Titrating too quickly: Weekly or biweekly increases prevent overwhelming side effects
3. Abandoning TCAs prematurely: Anticholinergic side effects often improve with continued use; consider switching from tertiary to secondary amines before abandoning the class entirely
4. Using traditional analgesics: NSAIDs and opioids are not appropriate for chronic functional epigastric pain and may worsen gastric symptoms

For Structural Causes (GERD, PUD, Gastritis)

When imaging or endoscopy identifies structural pathology 2, the focus shifts to treating the underlying condition rather than prescribing analgesics:

• GERD/esophagitis: Proton pump inhibitors are the primary treatment
• PUD/gastritis: H. pylori eradication and acid suppression
• Avoid NSAIDs: These worsen gastric and duodenal pathology

The neuromodulator approach outlined above applies specifically to functional disorders where structural causes have been excluded or adequately treated but pain persists.